Ever since cross-linking (CXL) technology was introduced into clinical ophthalmology in 1999, the technique has established itself as a standard of care in the treatment of corneal ectasia. The original protocol, referred to as the ‘Dresden protocol’, consisted of 30 minutes of iso-osmolaric riboflavin instillation on a de-epithelialised cornea, followed by irradiation at 365 nm and 3 mW/cm2 for 30 minutes. These settings correspond to a fluence of 5.4 J/cm2. A large variety of modifications of this original protocol have emerged in the past years: some of these modifications are backed up by a solid body of research evidence, both clinically and experimentally, whereas other modifications are based on little to no scientific evidence. Navigating through this ‘sea of new protocols’ is becoming increasingly difficult for the treating ophthalmologist. The two most important modifications are transepithelial (epi-on) CXL and accelerated CXL. Most interestingly, they seem to share a final common pathway, which determines efficacy: oxygen dependency.
Epi-on, transepithelial, iontophoresis, epi-off, corneal cross-linking, CXL, oxygen
Nikki Hafezi is Chief Executive Officer of EMAGine SA, Farhad Hafezi is Chief Medical Officer of EMAGine SA, and named co-inventor of PCT/CH 2012/000090
application (UV light source). No funding was received in the publication of this article.
Farhad Hafezi, ELZA Institute, Webereistrasse 2, CH – 8953 Dietikon. E: firstname.lastname@example.org
This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation
and reproduction provided the original author(s) and source are given appropriate credit.
Share this Article
Related Content In Anterior Segment
Pilocarpine Hydrochloride Ophthalmic Solution 1.25%: An Innovative Prescription Eye Drop for the Treatment of Presbyopia
touchREVIEWS in Ophthalmology. 2022;16(2):54–62 DOI: https://doi.org/10.17925/USOR.2022.16.2.54
Presbyopia is a progressive, age-related condition that reduces the eye’s ability to focus on near objects, due to gradual lens thickening and decline in its elasticity and accommodative capacity, and represents the first stage of the dysfunctional lens syndrome.1–3 Presbyopia typically affects individuals aged >40 years and is highly prevalent, affecting nearly 2 billion people worldwide […]
Paediatric Vernal Keratoconjunctivitis – The VEKTIS Study
European Ophthalmic Review. 2020;14(1):12–3 DOI: https://doi.org/10.17925/EOR.2020.14.1.12
Dominique Bremond-Gignac, MD, PhD, FEBO, is Professor of Ophthalmology and Head of the Department of Ophthalmology with a paediatric and ocular surface subspecialty at the University Hospital Necker–Enfants Malades and University of Paris in Paris, France. She graduated in pharmacology and statistics (MSc) and completed her PhD thesis in anatomy. Her activity is distributed across […]
I am delighted to welcome you to the Spring 2020 edition of US Ophthalmic Review. This edition features some wide-ranging and insightful articles from top names in ophthalmology from around the globe. We begin with an insightful Expert Interview with Deborah K VanderVeen, from Boston Children’s Hospital, about the rationale for the use of orthokeratology for the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!